VF
XBIT icon

Virtu Financial’s XBiotech XBIT Stock Holding History

Virtu Financial’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,735
Closed -$58K – 2120
2024
Q4 		$58K Buy
+14,735
New +$100K ﹤0.01% 1138
2023
Q3 		– Sell
-10,410
Closed -$62K – 1982
2023
Q2 		$62K Buy
+10,410
New +$47K ﹤0.01% 1114
2021
Q4 		– Sell
-12,111
Closed -$157K – 2235
2021
Q3 		$157K Buy
+12,111
New +$193K 0.01% 989
2019
Q1 		– Sell
-15,682
Closed -$80K – 1907
2018
Q4 		$80K Buy
+15,682
New +$64.3K ﹤0.01% 1189
2017
Q4 		– Sell
-11,527
Closed -$50K – 3090
2017
Q3 		$50K Buy
+11,527
New +$54.4K ﹤0.01% 2228

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's XBIT Position: Q1 2025 in Review

Virtu Financial sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 14,735 shares — an estimated $58K sold.

Virtu Financial first reported a position in XBIT in Q3 2017 and held it in 5 quarters. The position peaked at $157K in Q3 2021. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • Virtu Financial reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 14,735 XBiotech shares in Q1 2025, an estimated $58K.
  • Virtu Financial first reported a position in XBiotech in Q3 2017 and held it in 5 quarters.
  • Virtu Financial's XBiotech position peaked at $157K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.